Literature DB >> 15640154

Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.

Greg L Mayeur1, Wei-Jen Kung, Anthony Martinez, Chie Izumiya, David J Chen, Hsing-Jien Kung.   

Abstract

The androgen receptor (AR) dynamically assembles and disassembles multicomponent receptor complexes in order to respond rapidly and reversibly to fluctuations in androgen levels. We are interested in identifying the basal factors that compose the AR aporeceptor and holoreceptor complexes and impact the transcriptional process. Using tandem mass spectroscopy analysis, we identified the trimeric DNA-dependent protein kinase (DNA-PK) complex as the major AR-interacting proteins. AR directly interacts with both Ku70 and Ku80 in vivo and in vitro, as shown by co-immunoprecipitation, glutathione S-transferase pull-down, and Sf9 cell/baculovirus expression. The interaction was localized to the androgen receptor ligand binding domain and is independent of DNA interactions. Ku interacts with AR in the cytoplasm and nucleus regardless of the presence or absence of androgen. Ku acts as a coactivator of AR activity in a luciferase reporter assay employing both Ku-defective cells and Ku small interfering RNA knock-down in a prostate cancer cell line. DNA-PK catalytic subunit (DNA-PKcs) also acts as a coactivator of androgen receptor activity in a luciferase reporter assay employing DNA-PKcs defective cells. AR nuclear translocation is not affected in Ku defective cells, implying Ku functionality may be mainly nuclear. Chromatin immunoprecipitation experiments demonstrated that both Ku70 and Ku80 interact with the prostate-specific antigen promoter in an androgen-dependant manner. Finally, in vitro transcription assays demonstrated Ku involvement in transcriptional recycling with androgen dependent promoters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640154     DOI: 10.1074/jbc.M413336200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  A hormone-DNA repair circuit governs the response to genotoxic insult.

Authors:  Jonathan F Goodwin; Matthew J Schiewer; Jeffry L Dean; Randy S Schrecengost; Renée de Leeuw; Sumin Han; Teng Ma; Robert B Den; Adam P Dicker; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Discov       Date:  2013-09-11       Impact factor: 39.397

2.  Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro.

Authors:  Leonard C Shank; Joshua B Kelley; Daniel Gioeli; Chun-Song Yang; Adam Spencer; Lizabeth A Allison; Bryce M Paschal
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

3.  Complexes of DNA-dependent protein kinase with single-stranded oligo-(AGGG)6: identification and possible role in modulation of ribosomal RNA transcription.

Authors:  K K Netchvolodov; V S Kurova; A S Kononikhin; Y u A Savochkina; E N Nikolaevb; N S Kupriyanova; A P Ryskov; S D Varfolomeev
Journal:  Dokl Biochem Biophys       Date:  2009 Jan-Feb       Impact factor: 0.788

4.  Purification and identification of positive regulators binding to a novel element in the c-Jun promoter.

Authors:  Daifeng Jiang; YanWen Zhou; Robert A Moxley; Harry W Jarrett
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

5.  DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Authors:  Jonathan F Goodwin; Vishal Kothari; Justin M Drake; Shuang Zhao; Emanuela Dylgjeri; Jeffry L Dean; Matthew J Schiewer; Christopher McNair; Jennifer K Jones; Alvaro Aytes; Michael S Magee; Adam E Snook; Ziqi Zhu; Robert B Den; Ruth C Birbe; Leonard G Gomella; Nicholas A Graham; Ajay A Vashisht; James A Wohlschlegel; Thomas G Graeber; R Jeffrey Karnes; Mandeep Takhar; Elai Davicioni; Scott A Tomlins; Cory Abate-Shen; Nima Sharifi; Owen N Witte; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

6.  Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.

Authors:  Susan Evans-Axelsson; Oskar Vilhelmsson Timmermand; Charlotte Welinder; Carl Ak Borrebaeck; Sven-Erik Strand; Thuy A Tran; Bo Jansson; Anders Bjartell
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-06-07

Review 7.  The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.

Authors:  Michael W Drazer; Walter M Stadler
Journal:  Cancer J       Date:  2016 Sep/Oct       Impact factor: 3.360

8.  Ubiquitylation of Ku80 by RNF126 Promotes Completion of Nonhomologous End Joining-Mediated DNA Repair.

Authors:  Noriko Ishida; Tadashi Nakagawa; Shun-Ichiro Iemura; Akira Yasui; Hiroki Shima; Yasutake Katoh; Yuko Nagasawa; Toru Natsume; Kazuhiko Igarashi; Keiko Nakayama
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

Review 9.  The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer.

Authors:  Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-08-05       Impact factor: 5.678

10.  Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.

Authors:  Grégory Nolens; Jean-Christophe Pignon; Benjamin Koopmansch; Benaïssa Elmoualij; Willy Zorzi; Edwin De Pauw; Rosita Winkler
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.